Nara, Japan

Sanji Hagishita


Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 104(Granted Patents)


Location History:

  • Gose, JP (1998 - 2001)
  • Nara, JP (1989 - 2003)

Company Filing History:


Years Active: 1989-2003

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sanji Hagishita

Introduction

Sanji Hagishita is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 11 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Hagishita's latest patents include a class of novel indolizine-1-functional and indolizine-3-functional compounds. These compounds are designed to inhibit sPLA-mediated release of fatty acids, which can be crucial in treating conditions such as septic shock. The specific compounds he has developed include indolizine-1-acetamides, indolizine-1-acetic acid hydrazides, indolizine-1-glyoxylamides, indolizine-3-acetamides, indolizine-3-acetic acid hydrazides, and indolizine-3-glyoxylasides. Additionally, he has worked on indene-1-acetamide compounds that serve as sPLA2 inhibitors.

Career Highlights

Throughout his career, Sanji Hagishita has been associated with Shionogi & Company Limited, where he has contributed to various research initiatives. His innovative approach to drug development has positioned him as a key figure in his field.

Collaborations

Hagishita has collaborated with notable colleagues, including Kaoru Seno and Susumu Kamata. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Sanji Hagishita's work exemplifies the spirit of innovation in medicinal chemistry. His contributions through patents and collaborations continue to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…